131.96
-5.64 (-4.10%)
| Penutupan Terdahulu | 137.60 |
| Buka | 138.13 |
| Jumlah Dagangan | 1,359,901 |
| Purata Dagangan (3B) | 1,197,704 |
| Modal Pasaran | 7,443,565,568 |
| Harga / Pendapatan (P/E TTM) | 145.01 |
| Harga / Pendapatan (P/E Ke hadapan) | 66.67 |
| Harga / Jualan (P/S) | 9.78 |
| Harga / Buku (P/B) | 3.54 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Jul 2026 |
| Margin Keuntungan | -3.53% |
| Margin Operasi (TTM) | 5.59% |
| EPS Cair (TTM) | -0.420 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 76.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 34.44% |
| Nisbah Semasa (MRQ) | 6.79 |
| Aliran Tunai Operasi (OCF TTM) | 145.69 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 183.66 M |
| Pulangan Atas Aset (ROA TTM) | 0.92% |
| Pulangan Atas Ekuiti (ROE TTM) | -1.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | Repligen Corporation | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -3.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.88 |
|
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 6.41% |
| % Dimiliki oleh Institusi | 105.07% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| United Capital Financial Advisors, Llc | 31 Mar 2026 | 2,773,980 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| GARLAND JASON K | - | 148.55 | -530 | -78,732 |
| Jumlah Keseluruhan Kuantiti Bersih | -530 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -78,732 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 148.55 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| GARLAND JASON K | Pegawai | 16 Jul 2026 | Jual automatik (-) | 530 | 148.55 | 78,732 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |